United States:
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital To Acquire Harrington Process Solutions
26 September 2023
McGuireWoods LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Bain Capital Private Equity will acquire Harrington Process
Solutions, according to a news release.
Harrington, founded in 1959 and based in Chino, Calif., is a
specialty distributor of industrial flow control process solutions.
Harrington provides solutions to a wide range of industries,
including life sciences.
Bain Capital Private
Equity, based in Boston, focuses on making control and minority
equity investments and prefers to make more substantial investments
from a dollars perspective. Founded in 1984, the firm invests in
healthcare and several other industries, targeting companies with
revenue of at least $100 million. Within healthcare, Bain Capital
targets companies in the provider services, hospital/major
facilities, life sciences/pharmaceutical and non-reimbursement
industries.
Terms of the acquisition were not disclosed.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
A Practical Look At OIG's New Compliance Guidance
Goodwin Procter LLP
On November 6, 2023, for the first time in 15 years, HHS OIG issued a new reference guide for the health care compliance community – the General Compliance Program Guidance, or GCPG.
Who Regulates My Product?
Foley & Lardner
In the world of healthy food and beverages, a crucial first step towards bringing a new product to the crowded U.S. market is identifying and understanding...
FDA Issues Revised Off-Label Communications Guidance
Jones Day
The U.S. Food and Drug Administration ("FDA") has issued a revised draft guidance that seeks to address questions and provide recommendations regarding the sharing of scientific information with health care providers...
Best Practices For Orange Book Listings
Wolf, Greenfield & Sacks, P.C.
In 1984, Congress passed and the President signed into law the Drug Price Competition and Patent Term Restoration Act, better known as the Hatch-Waxman Act.